# Sympathetic Mapping/ Ablation of Renal Nerves Trial

Study · id `cardio:ct-nct02761811` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02761811](<https://clinicaltrials.gov/study/NCT02761811>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02761811

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 220 participants.

## Technical summary

Registry record NCT02761811. Randomized; single masking; primary purpose treatment. Start 2016-06-30 (registry gives no type); primary completion 2022-08-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 220 participants (enrolled count; ClinicalTrials.gov record NCT02761811, source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)
- Start date: 2016-06-30 (registry gives no type) (ClinicalTrials.gov record NCT02761811, source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)
- Primary completion: 2022-08-25 (actual) (ClinicalTrials.gov record NCT02761811, source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT02761811, source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02761811, source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02761811-2023-08-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sympathetic Mapping/ Ablation of Renal Nerves Trial
- Acronym: SMART
- Condition: Hypertension
- Intervention (Device): SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator
- Lead sponsor: SyMap Medical (Suzhou), Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Tigermed Consulting Co., Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as a collaborator: Tigermed Consulting Co., Ltd (`cardio:org-tigermed-consulting-co-ltd`)

## Provenance

Content hash: 10a10ff99d1573c34870e342986725acdcfbe3f3ba557a26a212a6e13fa68cc8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
